Anti-CD20 or anti-IgE therapy for sev... [J Allergy Clin Immunol. 2009] - PubMed

loading

Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. [J Allergy Clin Immunol. 2011]
Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies.
Chakravarty SD, Yee AF, Paget SA. J Allergy Clin Immunol. 2011 Dec; 128(6):1354-5. Epub 2011 Sep 28.
Review CD20: a target antigen for immunotherapy of autoimmune diseases. [Autoimmun Rev. 2005]
Review CD20: a target antigen for immunotherapy of autoimmune diseases.
Perosa F, Favoino E, Caragnano MA, Prete M, Dammacco F. Autoimmun Rev. 2005 Nov; 4(8):526-31.
Review CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. [J Intern Med. 2010]
Review CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.
Perosa F, Prete M, Racanelli V, Dammacco F. J Intern Med. 2010 Mar; 267(3):260-77.
Not all chronic urticaria is "idiopathic"! [Exp Dermatol. 1998]
Not all chronic urticaria is "idiopathic"!
Greaves MW, O'Donnell BF. Exp Dermatol. 1998 Feb; 7(1):11-3.
Late and long-lasting response in an adult chronic idiopathic thrombocytopenic purpura after extended course of rituximab. [Leuk Lymphoma. 2003]
Late and long-lasting response in an adult chronic idiopathic thrombocytopenic purpura after extended course of rituximab.
D'Arena G, Luigiavigliotti M, Coccaro M, Iodice G, Tartarone A, Matera R, Di Renzo N. Leuk Lymphoma. 2003 Mar; 44(3):561-2.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria.
Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria.
J Allergy Clin Immunol. 2009 Feb ;123(2):510-1; author reply 511.

PubMed
Preclinical development of the green tea catechin, epigallocatechin gallate, as ...
Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.
J Allergy Clin Immunol. 2009 Feb ;123(2):459-65.

PubMed
Household peanut consumption as a risk factor for the development of peanut alle...
Household peanut consumption as a risk factor for the development of peanut allergy.
J Allergy Clin Immunol. 2009 Feb ;123(2):417-23.

PubMed
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions t...
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008.
J Allergy Clin Immunol. 2009 Feb ;123(2):319-27.

PubMed
Efficacy and mechanisms of action of traditional Chinese medicines for treating ...
Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy.
J Allergy Clin Immunol. 2009 Feb ;123(2):297-306; quiz 307-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed